Legislation

Title: Maryland Health Insurance Coverage Protection Commission - Review of Drug Transparency and Notification Laws and Initiatives
Sponsored by: Senators Conway, Astle, Benson, Currie, Ferguson, Guzzone, Kelley, King, Lee, Madaleno, Manno, Mathias, McFadden, Muse, Nathan-Pulliam, Peters, Pinsky, Ramirez, Robinson, Rosapepe, Smith, Young, and Zucker
Status: In the House - First Reading House Rules and Executive Nominations
Analysis: Fiscal and Policy Note (Revised)

Synopsis

Requiring the Maryland Health Insurance Coverage Protection Commission to review specified prescription drug transparency and notification laws and initiatives and information for purposes of assessing proposals for the adoption and implementation of laws or other initiatives in the State; authorizing the Commission, as part of its review, to consider specified studies and to receive input from experts on prescription drug pricing; and making the Act subject to a specified contingency.

Committees

Original:: Finance Click to view Recorded Media

Opposite:: Rules and Executive Nominations

Details

Cross-filed with: HB0666

Bill File Type: Regular

Effective Date(s): June 1, 2017

Contingency - on enactment of another bill

History

Legislation History
Chamber Senate Calendar Date 1/30/2017 Legislative Date 1/30/2017 Action First Reading Finance Proceedings
Chamber Senate Calendar Date 1/30/2017 Legislative Date 1/30/2017 Action Hearing 2/15 at 1:00 p.m. Proceedings
Chamber Calendar Date Legislative Date Action Text - First - Public Health - Expensive Drugs - Manufacturer Reporting and Drug Price Transparency Advisory Committee Proceedings
Chamber Calendar Date Legislative Date Action Vote - Senate - Committee - Finance Proceedings Click to view Recorded Media
Chamber Senate Calendar Date 4/05/2017 Legislative Date 4/05/2017 Action Favorable with Amendments Report by Finance Proceedings
Chamber Senate Calendar Date 4/05/2017 Legislative Date 3/30/2017 Action Favorable with Amendments {417674/1 Adopted Proceedings 59 Click to view Recorded Media
Chamber Senate Calendar Date 4/05/2017 Legislative Date 3/30/2017 Action Second Reading Passed with Amendments Proceedings 59 Click to view Recorded Media
Chamber Calendar Date Legislative Date Action Text - Third - Maryland Health Insurance Coverage Protection Commission - Review of Drug Transparency and Notification Laws and Initiatives Proceedings
Chamber Senate Calendar Date 4/06/2017 Legislative Date 3/31/2017 Action Third Reading Passed (47-0) Proceedings 60 Click to view Recorded Media
Chamber House Calendar Date 4/06/2017 Legislative Date 3/30/2017 Action Referred Rules and Executive Nominations Proceedings 64 Click to view Recorded Media

Chamber	Calendar Date	Legislative Date	Action	Proceedings
Senate	1/30/2017	1/30/2017	First Reading Finance
Senate	1/30/2017	1/30/2017	Hearing 2/15 at 1:00 p.m.
			Text - First - Public Health - Expensive Drugs - Manufacturer Reporting and Drug Price Transparency Advisory Committee
			Vote - Senate - Committee - Finance	Click to view Recorded Media
Senate	4/05/2017	4/05/2017	Favorable with Amendments Report by Finance
Senate	4/05/2017	3/30/2017	Favorable with Amendments {417674/1 Adopted	59 Click to view Recorded Media
Senate	4/05/2017	3/30/2017	Second Reading Passed with Amendments	59 Click to view Recorded Media
			Text - Third - Maryland Health Insurance Coverage Protection Commission - Review of Drug Transparency and Notification Laws and Initiatives
Senate	4/06/2017	3/31/2017	Third Reading Passed (47-0)	60 Click to view Recorded Media
House	4/06/2017	3/30/2017	Referred Rules and Executive Nominations	64 Click to view Recorded Media

File Code

Subjects

Statutes